Global Cell Therapy and Acellular Therapy Market Research Report 2023

Publisher Name :
Date: 20-Jan-2023
No. of pages: 87
Inquire Before Buying

Highlights

The global Cell Therapy and Acellular Therapy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Cell Therapy and Acellular Therapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Cell Therapy and Acellular Therapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Cell Therapy and Acellular Therapy in Cardiology is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Cell Therapy and Acellular Therapy include Aegle Therapeutics Corp, ArunA Biomedical, Capricor Therapeutics, Inc., Codiak BioSciences, Inc., Direct Biologics, LLC, EV Therapeutics, Inc., Evox Therapeutics Ltd, Exogenus Therapeutics and Invitrx Therapeutics, Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cell Therapy and Acellular Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Therapy and Acellular Therapy.

The Cell Therapy and Acellular Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cell Therapy and Acellular Therapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cell Therapy and Acellular Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- Aegle Therapeutics Corp

- ArunA Biomedical

- Capricor Therapeutics, Inc.

- Codiak BioSciences, Inc.

- Direct Biologics, LLC

- EV Therapeutics, Inc.

- Evox Therapeutics Ltd

- Exogenus Therapeutics

- Invitrx Therapeutics, Inc.

- Organicell Regenerative Medicine, Inc.

- Rion LLC

- Stem Cell Medicine Ltd.

Segment by Type

- Cell Therapy

- Acellular Therapy

Segment by Application

- Cardiology

- Hepatology

- Neurology

- Gastroenterology

- Oncology

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cell Therapy and Acellular Therapy companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Cell Therapy and Acellular Therapy Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy and Acellular Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Cell Therapy
1.2.3 Acellular Therapy
1.3 Market by Application
1.3.1 Global Cell Therapy and Acellular Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cardiology
1.3.3 Hepatology
1.3.4 Neurology
1.3.5 Gastroenterology
1.3.6 Oncology
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Therapy and Acellular Therapy Market Perspective (2018-2029)
2.2 Cell Therapy and Acellular Therapy Growth Trends by Region
2.2.1 Global Cell Therapy and Acellular Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell Therapy and Acellular Therapy Historic Market Size by Region (2018-2023)
2.2.3 Cell Therapy and Acellular Therapy Forecasted Market Size by Region (2024-2029)
2.3 Cell Therapy and Acellular Therapy Market Dynamics
2.3.1 Cell Therapy and Acellular Therapy Industry Trends
2.3.2 Cell Therapy and Acellular Therapy Market Drivers
2.3.3 Cell Therapy and Acellular Therapy Market Challenges
2.3.4 Cell Therapy and Acellular Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Therapy and Acellular Therapy Players by Revenue
3.1.1 Global Top Cell Therapy and Acellular Therapy Players by Revenue (2018-2023)
3.1.2 Global Cell Therapy and Acellular Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Cell Therapy and Acellular Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Therapy and Acellular Therapy Revenue
3.4 Global Cell Therapy and Acellular Therapy Market Concentration Ratio
3.4.1 Global Cell Therapy and Acellular Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy and Acellular Therapy Revenue in 2022
3.5 Cell Therapy and Acellular Therapy Key Players Head office and Area Served
3.6 Key Players Cell Therapy and Acellular Therapy Product Solution and Service
3.7 Date of Enter into Cell Therapy and Acellular Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Therapy and Acellular Therapy Breakdown Data by Type
4.1 Global Cell Therapy and Acellular Therapy Historic Market Size by Type (2018-2023)
4.2 Global Cell Therapy and Acellular Therapy Forecasted Market Size by Type (2024-2029)
5 Cell Therapy and Acellular Therapy Breakdown Data by Application
5.1 Global Cell Therapy and Acellular Therapy Historic Market Size by Application (2018-2023)
5.2 Global Cell Therapy and Acellular Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cell Therapy and Acellular Therapy Market Size (2018-2029)
6.2 North America Cell Therapy and Acellular Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cell Therapy and Acellular Therapy Market Size by Country (2018-2023)
6.4 North America Cell Therapy and Acellular Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Therapy and Acellular Therapy Market Size (2018-2029)
7.2 Europe Cell Therapy and Acellular Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cell Therapy and Acellular Therapy Market Size by Country (2018-2023)
7.4 Europe Cell Therapy and Acellular Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy and Acellular Therapy Market Size (2018-2029)
8.2 Asia-Pacific Cell Therapy and Acellular Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cell Therapy and Acellular Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Cell Therapy and Acellular Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Therapy and Acellular Therapy Market Size (2018-2029)
9.2 Latin America Cell Therapy and Acellular Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cell Therapy and Acellular Therapy Market Size by Country (2018-2023)
9.4 Latin America Cell Therapy and Acellular Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Therapy and Acellular Therapy Market Size (2018-2029)
10.2 Middle East & Africa Cell Therapy and Acellular Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cell Therapy and Acellular Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Cell Therapy and Acellular Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aegle Therapeutics Corp
11.1.1 Aegle Therapeutics Corp Company Detail
11.1.2 Aegle Therapeutics Corp Business Overview
11.1.3 Aegle Therapeutics Corp Cell Therapy and Acellular Therapy Introduction
11.1.4 Aegle Therapeutics Corp Revenue in Cell Therapy and Acellular Therapy Business (2018-2023)
11.1.5 Aegle Therapeutics Corp Recent Development
11.2 ArunA Biomedical
11.2.1 ArunA Biomedical Company Detail
11.2.2 ArunA Biomedical Business Overview
11.2.3 ArunA Biomedical Cell Therapy and Acellular Therapy Introduction
11.2.4 ArunA Biomedical Revenue in Cell Therapy and Acellular Therapy Business (2018-2023)
11.2.5 ArunA Biomedical Recent Development
11.3 Capricor Therapeutics, Inc.
11.3.1 Capricor Therapeutics, Inc. Company Detail
11.3.2 Capricor Therapeutics, Inc. Business Overview
11.3.3 Capricor Therapeutics, Inc. Cell Therapy and Acellular Therapy Introduction
11.3.4 Capricor Therapeutics, Inc. Revenue in Cell Therapy and Acellular Therapy Business (2018-2023)
11.3.5 Capricor Therapeutics, Inc. Recent Development
11.4 Codiak BioSciences, Inc.
11.4.1 Codiak BioSciences, Inc. Company Detail
11.4.2 Codiak BioSciences, Inc. Business Overview
11.4.3 Codiak BioSciences, Inc. Cell Therapy and Acellular Therapy Introduction
11.4.4 Codiak BioSciences, Inc. Revenue in Cell Therapy and Acellular Therapy Business (2018-2023)
11.4.5 Codiak BioSciences, Inc. Recent Development
11.5 Direct Biologics, LLC
11.5.1 Direct Biologics, LLC Company Detail
11.5.2 Direct Biologics, LLC Business Overview
11.5.3 Direct Biologics, LLC Cell Therapy and Acellular Therapy Introduction
11.5.4 Direct Biologics, LLC Revenue in Cell Therapy and Acellular Therapy Business (2018-2023)
11.5.5 Direct Biologics, LLC Recent Development
11.6 EV Therapeutics, Inc.
11.6.1 EV Therapeutics, Inc. Company Detail
11.6.2 EV Therapeutics, Inc. Business Overview
11.6.3 EV Therapeutics, Inc. Cell Therapy and Acellular Therapy Introduction
11.6.4 EV Therapeutics, Inc. Revenue in Cell Therapy and Acellular Therapy Business (2018-2023)
11.6.5 EV Therapeutics, Inc. Recent Development
11.7 Evox Therapeutics Ltd
11.7.1 Evox Therapeutics Ltd Company Detail
11.7.2 Evox Therapeutics Ltd Business Overview
11.7.3 Evox Therapeutics Ltd Cell Therapy and Acellular Therapy Introduction
11.7.4 Evox Therapeutics Ltd Revenue in Cell Therapy and Acellular Therapy Business (2018-2023)
11.7.5 Evox Therapeutics Ltd Recent Development
11.8 Exogenus Therapeutics
11.8.1 Exogenus Therapeutics Company Detail
11.8.2 Exogenus Therapeutics Business Overview
11.8.3 Exogenus Therapeutics Cell Therapy and Acellular Therapy Introduction
11.8.4 Exogenus Therapeutics Revenue in Cell Therapy and Acellular Therapy Business (2018-2023)
11.8.5 Exogenus Therapeutics Recent Development
11.9 Invitrx Therapeutics, Inc.
11.9.1 Invitrx Therapeutics, Inc. Company Detail
11.9.2 Invitrx Therapeutics, Inc. Business Overview
11.9.3 Invitrx Therapeutics, Inc. Cell Therapy and Acellular Therapy Introduction
11.9.4 Invitrx Therapeutics, Inc. Revenue in Cell Therapy and Acellular Therapy Business (2018-2023)
11.9.5 Invitrx Therapeutics, Inc. Recent Development
11.10 Organicell Regenerative Medicine, Inc.
11.10.1 Organicell Regenerative Medicine, Inc. Company Detail
11.10.2 Organicell Regenerative Medicine, Inc. Business Overview
11.10.3 Organicell Regenerative Medicine, Inc. Cell Therapy and Acellular Therapy Introduction
11.10.4 Organicell Regenerative Medicine, Inc. Revenue in Cell Therapy and Acellular Therapy Business (2018-2023)
11.10.5 Organicell Regenerative Medicine, Inc. Recent Development
11.11 Rion LLC
11.11.1 Rion LLC Company Detail
11.11.2 Rion LLC Business Overview
11.11.3 Rion LLC Cell Therapy and Acellular Therapy Introduction
11.11.4 Rion LLC Revenue in Cell Therapy and Acellular Therapy Business (2018-2023)
11.11.5 Rion LLC Recent Development
11.12 Stem Cell Medicine Ltd.
11.12.1 Stem Cell Medicine Ltd. Company Detail
11.12.2 Stem Cell Medicine Ltd. Business Overview
11.12.3 Stem Cell Medicine Ltd. Cell Therapy and Acellular Therapy Introduction
11.12.4 Stem Cell Medicine Ltd. Revenue in Cell Therapy and Acellular Therapy Business (2018-2023)
11.12.5 Stem Cell Medicine Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cell Therapy and Acellular Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Acellular Therapy
Table 4. Global Cell Therapy and Acellular Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Cell Therapy and Acellular Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Cell Therapy and Acellular Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Cell Therapy and Acellular Therapy Market Share by Region (2018-2023)
Table 8. Global Cell Therapy and Acellular Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Cell Therapy and Acellular Therapy Market Share by Region (2024-2029)
Table 10. Cell Therapy and Acellular Therapy Market Trends
Table 11. Cell Therapy and Acellular Therapy Market Drivers
Table 12. Cell Therapy and Acellular Therapy Market Challenges
Table 13. Cell Therapy and Acellular Therapy Market Restraints
Table 14. Global Cell Therapy and Acellular Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Cell Therapy and Acellular Therapy Market Share by Players (2018-2023)
Table 16. Global Top Cell Therapy and Acellular Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy and Acellular Therapy as of 2022)
Table 17. Ranking of Global Top Cell Therapy and Acellular Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Cell Therapy and Acellular Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cell Therapy and Acellular Therapy Product Solution and Service
Table 21. Date of Enter into Cell Therapy and Acellular Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell Therapy and Acellular Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Cell Therapy and Acellular Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Cell Therapy and Acellular Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Cell Therapy and Acellular Therapy Revenue Market Share by Type (2024-2029)
Table 27. Global Cell Therapy and Acellular Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Cell Therapy and Acellular Therapy Revenue Market Share by Application (2018-2023)
Table 29. Global Cell Therapy and Acellular Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Cell Therapy and Acellular Therapy Revenue Market Share by Application (2024-2029)
Table 31. North America Cell Therapy and Acellular Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Cell Therapy and Acellular Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Cell Therapy and Acellular Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Cell Therapy and Acellular Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Cell Therapy and Acellular Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Cell Therapy and Acellular Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Cell Therapy and Acellular Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Cell Therapy and Acellular Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Cell Therapy and Acellular Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Cell Therapy and Acellular Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Cell Therapy and Acellular Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Cell Therapy and Acellular Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Cell Therapy and Acellular Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Cell Therapy and Acellular Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Cell Therapy and Acellular Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. Aegle Therapeutics Corp Company Detail
Table 47. Aegle Therapeutics Corp Business Overview
Table 48. Aegle Therapeutics Corp Cell Therapy and Acellular Therapy Product
Table 49. Aegle Therapeutics Corp Revenue in Cell Therapy and Acellular Therapy Business (2018-2023) & (US$ Million)
Table 50. Aegle Therapeutics Corp Recent Development
Table 51. ArunA Biomedical Company Detail
Table 52. ArunA Biomedical Business Overview
Table 53. ArunA Biomedical Cell Therapy and Acellular Therapy Product
Table 54. ArunA Biomedical Revenue in Cell Therapy and Acellular Therapy Business (2018-2023) & (US$ Million)
Table 55. ArunA Biomedical Recent Development
Table 56. Capricor Therapeutics, Inc. Company Detail
Table 57. Capricor Therapeutics, Inc. Business Overview
Table 58. Capricor Therapeutics, Inc. Cell Therapy and Acellular Therapy Product
Table 59. Capricor Therapeutics, Inc. Revenue in Cell Therapy and Acellular Therapy Business (2018-2023) & (US$ Million)
Table 60. Capricor Therapeutics, Inc. Recent Development
Table 61. Codiak BioSciences, Inc. Company Detail
Table 62. Codiak BioSciences, Inc. Business Overview
Table 63. Codiak BioSciences, Inc. Cell Therapy and Acellular Therapy Product
Table 64. Codiak BioSciences, Inc. Revenue in Cell Therapy and Acellular Therapy Business (2018-2023) & (US$ Million)
Table 65. Codiak BioSciences, Inc. Recent Development
Table 66. Direct Biologics, LLC Company Detail
Table 67. Direct Biologics, LLC Business Overview
Table 68. Direct Biologics, LLC Cell Therapy and Acellular Therapy Product
Table 69. Direct Biologics, LLC Revenue in Cell Therapy and Acellular Therapy Business (2018-2023) & (US$ Million)
Table 70. Direct Biologics, LLC Recent Development
Table 71. EV Therapeutics, Inc. Company Detail
Table 72. EV Therapeutics, Inc. Business Overview
Table 73. EV Therapeutics, Inc. Cell Therapy and Acellular Therapy Product
Table 74. EV Therapeutics, Inc. Revenue in Cell Therapy and Acellular Therapy Business (2018-2023) & (US$ Million)
Table 75. EV Therapeutics, Inc. Recent Development
Table 76. Evox Therapeutics Ltd Company Detail
Table 77. Evox Therapeutics Ltd Business Overview
Table 78. Evox Therapeutics Ltd Cell Therapy and Acellular Therapy Product
Table 79. Evox Therapeutics Ltd Revenue in Cell Therapy and Acellular Therapy Business (2018-2023) & (US$ Million)
Table 80. Evox Therapeutics Ltd Recent Development
Table 81. Exogenus Therapeutics Company Detail
Table 82. Exogenus Therapeutics Business Overview
Table 83. Exogenus Therapeutics Cell Therapy and Acellular Therapy Product
Table 84. Exogenus Therapeutics Revenue in Cell Therapy and Acellular Therapy Business (2018-2023) & (US$ Million)
Table 85. Exogenus Therapeutics Recent Development
Table 86. Invitrx Therapeutics, Inc. Company Detail
Table 87. Invitrx Therapeutics, Inc. Business Overview
Table 88. Invitrx Therapeutics, Inc. Cell Therapy and Acellular Therapy Product
Table 89. Invitrx Therapeutics, Inc. Revenue in Cell Therapy and Acellular Therapy Business (2018-2023) & (US$ Million)
Table 90. Invitrx Therapeutics, Inc. Recent Development
Table 91. Organicell Regenerative Medicine, Inc. Company Detail
Table 92. Organicell Regenerative Medicine, Inc. Business Overview
Table 93. Organicell Regenerative Medicine, Inc. Cell Therapy and Acellular Therapy Product
Table 94. Organicell Regenerative Medicine, Inc. Revenue in Cell Therapy and Acellular Therapy Business (2018-2023) & (US$ Million)
Table 95. Organicell Regenerative Medicine, Inc. Recent Development
Table 96. Rion LLC Company Detail
Table 97. Rion LLC Business Overview
Table 98. Rion LLC Cell Therapy and Acellular Therapy Product
Table 99. Rion LLC Revenue in Cell Therapy and Acellular Therapy Business (2018-2023) & (US$ Million)
Table 100. Rion LLC Recent Development
Table 101. Stem Cell Medicine Ltd. Company Detail
Table 102. Stem Cell Medicine Ltd. Business Overview
Table 103. Stem Cell Medicine Ltd. Cell Therapy and Acellular Therapy Product
Table 104. Stem Cell Medicine Ltd. Revenue in Cell Therapy and Acellular Therapy Business (2018-2023) & (US$ Million)
Table 105. Stem Cell Medicine Ltd. Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Therapy and Acellular Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cell Therapy and Acellular Therapy Market Share by Type: 2022 VS 2029
Figure 3. Cell Therapy Features
Figure 4. Acellular Therapy Features
Figure 5. Global Cell Therapy and Acellular Therapy Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Cell Therapy and Acellular Therapy Market Share by Application: 2022 VS 2029
Figure 7. Cardiology Case Studies
Figure 8. Hepatology Case Studies
Figure 9. Neurology Case Studies
Figure 10. Gastroenterology Case Studies
Figure 11. Oncology Case Studies
Figure 12. Cell Therapy and Acellular Therapy Report Years Considered
Figure 13. Global Cell Therapy and Acellular Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Cell Therapy and Acellular Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Cell Therapy and Acellular Therapy Market Share by Region: 2022 VS 2029
Figure 16. Global Cell Therapy and Acellular Therapy Market Share by Players in 2022
Figure 17. Global Top Cell Therapy and Acellular Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy and Acellular Therapy as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Cell Therapy and Acellular Therapy Revenue in 2022
Figure 19. North America Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Cell Therapy and Acellular Therapy Market Share by Country (2018-2029)
Figure 21. United States Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Cell Therapy and Acellular Therapy Market Share by Country (2018-2029)
Figure 25. Germany Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Cell Therapy and Acellular Therapy Market Share by Region (2018-2029)
Figure 33. China Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Cell Therapy and Acellular Therapy Market Share by Country (2018-2029)
Figure 41. Mexico Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Cell Therapy and Acellular Therapy Market Share by Country (2018-2029)
Figure 45. Turkey Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Cell Therapy and Acellular Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Aegle Therapeutics Corp Revenue Growth Rate in Cell Therapy and Acellular Therapy Business (2018-2023)
Figure 48. ArunA Biomedical Revenue Growth Rate in Cell Therapy and Acellular Therapy Business (2018-2023)
Figure 49. Capricor Therapeutics, Inc. Revenue Growth Rate in Cell Therapy and Acellular Therapy Business (2018-2023)
Figure 50. Codiak BioSciences, Inc. Revenue Growth Rate in Cell Therapy and Acellular Therapy Business (2018-2023)
Figure 51. Direct Biologics, LLC Revenue Growth Rate in Cell Therapy and Acellular Therapy Business (2018-2023)
Figure 52. EV Therapeutics, Inc. Revenue Growth Rate in Cell Therapy and Acellular Therapy Business (2018-2023)
Figure 53. Evox Therapeutics Ltd Revenue Growth Rate in Cell Therapy and Acellular Therapy Business (2018-2023)
Figure 54. Exogenus Therapeutics Revenue Growth Rate in Cell Therapy and Acellular Therapy Business (2018-2023)
Figure 55. Invitrx Therapeutics, Inc. Revenue Growth Rate in Cell Therapy and Acellular Therapy Business (2018-2023)
Figure 56. Organicell Regenerative Medicine, Inc. Revenue Growth Rate in Cell Therapy and Acellular Therapy Business (2018-2023)
Figure 57. Rion LLC Revenue Growth Rate in Cell Therapy and Acellular Therapy Business (2018-2023)
Figure 58. Stem Cell Medicine Ltd. Revenue Growth Rate in Cell Therapy and Acellular Therapy Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs